APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neuromodulation Devices and Implantable Infusion Pumps

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Selected research

Industry Growth & Trends

Global Neuromodulation Devices and Implantable Infusion Pumps Industry Growth and Trends Forecast to 2032

Report ID 173916380120 December 2025100 pages

Choose your research edition.

Industry ResearchNeuromodulation Devices and Implantable Infusion Pumps Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuromodulation Devices and Implantable Infusion Pumps Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Neuromodulation Devices and Implantable Infusion Pumps Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.

Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.

Read the full market overview

In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.

Report Scope

This report provides a structured, data-driven view of the global Neuromodulation Devices and Implantable Infusion Pumps market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neuromodulation Devices and Implantable Infusion Pumps market size, estimates, and forecasts are presented in terms of sales volume (Unit) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neuromodulation Devices and Implantable Infusion Pumps market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neuromodulation Devices and Implantable Infusion Pumps.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neuromodulation Devices and Implantable Infusion Pumps market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neuromodulation Devices and Implantable Infusion Pumps Market by Company

Medtronic

Boston Scientific Corporation

St. Jude Medical

Synapse Biomedical

Nevro Corporation

Neuropace

Cyberonics

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

Neuromodulation Devices and Implantable Infusion Pumps Segment by Type

Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagal Nerve Stimulation

Gastric Stimulation

Transcranial Magnetic Stimulation

Transcutaneous Electrical Stimulation

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Application

Parkinson's Disease

Epilepsy

Pain

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuromodulation Devices and Implantable Infusion Pumps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuromodulation Devices and Implantable Infusion Pumps and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuromodulation Devices and Implantable Infusion Pumps.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neuromodulation Devices and Implantable Infusion Pumps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Spinal Cord Stimulation Table 2. Major Company of Deep Brain Stimulation Table 3. Major Company of Sacral Nerve Stimulation Table 4. Major Company of Vagal Nerve Stimulation Table 5. Major Company of Gastric Stimulation Table 6. Major Company of Transcranial Magnetic Stimulation Table 7. Major Company of Transcutaneous Electrical Stimulation Table 8. Major Company of Other Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type (2021-2026) Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (US$ Million) Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type (2021-2026) Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2026) & (USD/Unit) Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type (2027-2032) Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (US$ Million) Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type (2027-2032) Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2027-2032) & (USD/Unit) Table 20. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 21. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (US$ Million) Table 22. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 23. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 25. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 27. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 29. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (US$ Million) Table 30. Neuromodulation Devices and Implantable Infusion Pumps Industry Trends Table 31. Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers Table 32. Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges Table 33. Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2021-2026) Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2021-2026) & (Unit) Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Company (2021-2026) Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Market Price by Company (2021-2026) & (USD/Unit) Table 39. Global Neuromodulation Devices and Implantable Infusion Pumps Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global Neuromodulation Devices and Implantable Infusion Pumps Major Company Production Sites and Headquarters Table 41. Global Neuromodulation Devices and Implantable Infusion Pumps Company, Product Type & Application Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (Unit) Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Region (2021-2026) Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (US$ Million) Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Region (2021-2026) Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2027-2032) & (Unit) Table 52. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Region (2027-2032) Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2027-2032) & (US$ Million) Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Region (2027-2032) Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 56. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 58. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application (2021-2026) Table 59. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (US$ Million) Table 60. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application (2021-2026) Table 61. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2026) & (USD/Unit) Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application (2027-2032) Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (US$ Million) Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application (2027-2032) Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2027-2032) & (USD/Unit) Table 67. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 68. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (US$ Million) Table 69. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 70. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 72. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 74. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 76. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (US$ Million) Table 77. Medtronic Company Information Table 78. Medtronic Business Overview Table 79. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 81. Medtronic Recent Development Table 82. Boston Scientific Corporation Company Information Table 83. Boston Scientific Corporation Business Overview Table 84. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 86. Boston Scientific Corporation Recent Development Table 87. St. Jude Medical Company Information Table 88. St. Jude Medical Business Overview Table 89. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 91. St. Jude Medical Recent Development Table 92. Synapse Biomedical Company Information Table 93. Synapse Biomedical Business Overview Table 94. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 96. Synapse Biomedical Recent Development Table 97. Nevro Corporation Company Information Table 98. Nevro Corporation Business Overview Table 99. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 101. Nevro Corporation Recent Development Table 102. Neuropace Company Information Table 103. Neuropace Business Overview Table 104. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 106. Neuropace Recent Development Table 107. Cyberonics Company Information Table 108. Cyberonics Business Overview Table 109. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 111. Cyberonics Recent Development Table 112. Autonomic Technologies Company Information Table 113. Autonomic Technologies Business Overview Table 114. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 116. Autonomic Technologies Recent Development Table 117. Avery Biomedical Company Information Table 118. Avery Biomedical Business Overview Table 119. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 121. Avery Biomedical Recent Development Table 122. Greatbatch Medical Company Information Table 123. Greatbatch Medical Business Overview Table 124. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 126. Greatbatch Medical Recent Development Table 127. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (Unit): 2021 VS 2025 VS 2032 Table 128. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 129. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026) Table 130. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit) Table 131. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Country (2027-2032) Table 132. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country (2021-2026) Table 135. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Country (2027-2032) Table 137. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (Unit): 2021 VS 2025 VS 2032 Table 138. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 139. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026) Table 140. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit) Table 141. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country (2021-2026) Table 145. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (Unit): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 149. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit) Table 151. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country (2021-2026) Table 155. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Country (2027-2032) Table 157. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (Unit): 2021 VS 2025 VS 2032 Table 158. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 159. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026) Table 160. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit) Table 161. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country (2021-2026) Table 165. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (Unit): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 169. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032) & (Unit) Table 171. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country (2021-2026) Table 175. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Neuromodulation Devices and Implantable Infusion Pumps Distributors List Table 180. Neuromodulation Devices and Implantable Infusion Pumps Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Image Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (2021-2032) & (Unit) Figure 5. Spinal Cord Stimulation Image Figure 6. Global Spinal Cord Stimulation Sales YoY Growth (2021-2032) & (Unit) Figure 7. Deep Brain Stimulation Image Figure 8. Global Deep Brain Stimulation Sales YoY Growth (2021-2032) & (Unit) Figure 9. Sacral Nerve Stimulation Image Figure 10. Global Sacral Nerve Stimulation Sales YoY Growth (2021-2032) & (Unit) Figure 11. Vagal Nerve Stimulation Image Figure 12. Global Vagal Nerve Stimulation Sales YoY Growth (2021-2032) & (Unit) Figure 13. Gastric Stimulation Image Figure 14. Global Gastric Stimulation Sales YoY Growth (2021-2032) & (Unit) Figure 15. Transcranial Magnetic Stimulation Image Figure 16. Global Transcranial Magnetic Stimulation Sales YoY Growth (2021-2032) & (Unit) Figure 17. Transcutaneous Electrical Stimulation Image Figure 18. Global Transcutaneous Electrical Stimulation Sales YoY Growth (2021-2032) & (Unit) Figure 19. Other Image Figure 20. Global Other Sales YoY Growth (2021-2032) & (Unit) Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Type 2025 VS 2032 Figure 23. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type in 2025 Figure 24. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type in 2025 Figure 25. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type in 2025 Figure 26. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type in 2025 Figure 29. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type in 2025 Figure 30. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Parkinson's Disease Image Figure 36. Global Parkinson's Disease Sales YoY Growth (2021-2032) & (Unit) Figure 37. Epilepsy Image Figure 38. Global Epilepsy Sales YoY Growth (2021-2032) & (Unit) Figure 39. Pain Image Figure 40. Global Pain Sales YoY Growth (2021-2032) & (Unit) Figure 41. Other Image Figure 42. Global Other Sales YoY Growth (2021-2032) & (Unit) Figure 43. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application 2025 VS 2032 Figure 45. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application in 2025 Figure 46. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application in 2025 Figure 47. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application in 2025 Figure 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application in 2025 Figure 51. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share in Value by Application in 2025 Figure 55. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country: 2021 VS 2025 VS 2032 (Unit) Figure 56. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country: 2021 VS 2025 VS 2032 (Unit) Figure 60. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country: 2021 VS 2025 VS 2032 (Unit) Figure 64. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country: 2021 VS 2025 VS 2032 (Unit) Figure 68. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country: 2021 VS 2025 VS 2032 (Unit) Figure 72. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Neuromodulation Devices and Implantable Infusion Pumps Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Vagal Nerve Stimulation
  • Gastric Stimulation
  • Transcranial Magnetic Stimulation
  • Transcutaneous Electrical Stimulation
  • Other
Applications
  • Parkinson's Disease
  • Epilepsy
  • Pain
  • Other
Companies covered
  • Medtronic
  • Boston Scientific Corporation
  • St. Jude Medical
  • Synapse Biomedical
  • Nevro Corporation
  • Neuropace
  • Cyberonics
  • Autonomic Technologies
  • Avery Biomedical
  • Greatbatch Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neuromodulation Devices and Implantable Infusion Pumps Market by Type
  6. 1.3.1 Spinal Cord Stimulation
  7. 1.3.2 Deep Brain Stimulation
  8. 1.3.3 Sacral Nerve Stimulation
  9. 1.3.4 Vagal Nerve Stimulation
  10. 1.3.5 Gastric Stimulation
  11. 1.3.6 Transcranial Magnetic Stimulation
  12. 1.3.7 Transcutaneous Electrical Stimulation
  13. 1.3.8 Other
  14. 1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  15. 1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
  2. 2.2 Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers
  3. 2.3 Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges
  4. 2.4 Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2026)
  2. 3.2 Global Top Players by Neuromodulation Devices and Implantable Infusion Pumps Sales (2021-2026)
  3. 3.3 Global Top Players by Neuromodulation Devices and Implantable Infusion Pumps Price (2021-2026)
  4. 3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neuromodulation Devices and Implantable Infusion Pumps Major Company Production Sites & Headquarters
  6. 3.6 Global Neuromodulation Devices and Implantable Infusion Pumps Company, Product Type & Application
  7. 3.7 Global Neuromodulation Devices and Implantable Infusion Pumps Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neuromodulation Devices and Implantable Infusion Pumps Tier 1, Tier 2, and Tier 3
4 Neuromodulation Devices and Implantable Infusion Pumps Regional Status and Outlook
  1. 4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Size by Region
  3. 4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Market Size by Region
  7. 4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neuromodulation Devices and Implantable Infusion Pumps by Application
  1. 5.1 Neuromodulation Devices and Implantable Infusion Pumps Market by Application
  2. 5.1.1 Parkinson's Disease
  3. 5.1.2 Epilepsy
  4. 5.1.3 Pain
  5. 5.1.4 Other
  6. 5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  7. 5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Boston Scientific Corporation
  8. 6.2.1 Boston Scientific Corporation Company Information
  9. 6.2.2 Boston Scientific Corporation Business Overview
  10. 6.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  12. 6.2.5 Boston Scientific Corporation Recent Developments
  13. 6.3 St. Jude Medical
  14. 6.3.1 St. Jude Medical Company Information
  15. 6.3.2 St. Jude Medical Business Overview
  16. 6.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  18. 6.3.5 St. Jude Medical Recent Developments
  19. 6.4 Synapse Biomedical
  20. 6.4.1 Synapse Biomedical Company Information
  21. 6.4.2 Synapse Biomedical Business Overview
  22. 6.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  24. 6.4.5 Synapse Biomedical Recent Developments
  25. 6.5 Nevro Corporation
  26. 6.5.1 Nevro Corporation Company Information
  27. 6.5.2 Nevro Corporation Business Overview
  28. 6.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  30. 6.5.5 Nevro Corporation Recent Developments
  31. 6.6 Neuropace
  32. 6.6.1 Neuropace Company Information
  33. 6.6.2 Neuropace Business Overview
  34. 6.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  36. 6.6.5 Neuropace Recent Developments
  37. 6.7 Cyberonics
  38. 6.7.1 Cyberonics Company Information
  39. 6.7.2 Cyberonics Business Overview
  40. 6.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  42. 6.7.5 Cyberonics Recent Developments
  43. 6.8 Autonomic Technologies
  44. 6.8.1 Autonomic Technologies Company Information
  45. 6.8.2 Autonomic Technologies Business Overview
  46. 6.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  48. 6.8.5 Autonomic Technologies Recent Developments
  49. 6.9 Avery Biomedical
  50. 6.9.1 Avery Biomedical Company Information
  51. 6.9.2 Avery Biomedical Business Overview
  52. 6.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  54. 6.9.5 Avery Biomedical Recent Developments
  55. 6.10 Greatbatch Medical
  56. 6.10.1 Greatbatch Medical Company Information
  57. 6.10.2 Greatbatch Medical Business Overview
  58. 6.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  60. 6.10.5 Greatbatch Medical Recent Developments
7 North America by Country
  1. 7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
  2. 7.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  4. 7.1.3 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  6. 7.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026)
  8. 7.2.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
  2. 8.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  4. 8.1.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  6. 8.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
  2. 9.1.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  6. 9.2.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
  2. 10.1.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  4. 10.1.3 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  6. 10.2.1 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026)
  8. 10.2.3 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
  2. 11.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  6. 11.2.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
  2. 12.1.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
  7. 12.2 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
  10. 12.2.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst